Daiwa Securities Group Inc. Surface Oncology, Inc. Transaction History

Daiwa Securities Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	BUY	$6.87 - $10.48 $528 - $806	77 New	77 $1,000
Q4 2019 Jan 31, 2020	SELL	$1.17 - $2.33 $211 - $421	-181 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$4.11 - $5.88 $743 - $1,064	181 New	181 $1,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.